tq-b3139
Showing 1 - 4 of 4
Non Small Cell Lung Cancer Trial in China (TQ-B3139)
Recruiting
- Non Small Cell Lung Cancer
- TQ-B3139
-
Hefei, Anhui, China
- +15 more
Sep 10, 2020
ALK-positive NSCLC Trial in Guangzhou (TQ-B3139, Crizotinib)
Recruiting
- ALK-positive NSCLC
- TQ-B3139
- Crizotinib
-
Guangzhou, Guangdong, ChinaSun Yat-Sen University Cancer Center
Oct 29, 2019
ALK-positive NSCLC Trial in Guangzhou, Changsha (TQ-B3139)
Unknown status
- ALK-positive NSCLC
- TQ-B3139
-
Guangzhou, Guangdong, China
- +1 more
Oct 29, 2019
Advanced Cancer Trial in Guangzhou (TQ-B3139)
Unknown status
- Advanced Cancer
- TQ-B3139
-
Guangzhou, Guangdong, ChinaSun-Yat-Sen University Cancer Center
Sep 15, 2017